12/19
02:06 am
valn
Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India [Yahoo! Finance]
High
Report
Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India [Yahoo! Finance]
12/19
02:00 am
valn
Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India
High
Report
Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India
12/4
01:05 am
valn
Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal [Yahoo! Finance]
Medium
Report
Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal [Yahoo! Finance]
12/4
01:00 am
valn
Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal
Medium
Report
Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal
12/3
01:07 am
valn
Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® [Yahoo! Finance]
Low
Report
Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® [Yahoo! Finance]
12/3
01:00 am
valn
Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®
Low
Report
Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®
11/28
11:38 am
valn
Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock [Yahoo! Finance]
Low
Report
Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock [Yahoo! Finance]
11/26
11:45 am
valn
Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA
Neutral
Report
Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA
11/13
11:48 am
valn
Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2 [Yahoo! Finance]
Low
Report
Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2 [Yahoo! Finance]
11/13
11:45 am
valn
Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2
Low
Report
Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2
11/12
01:00 am
valn
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
Medium
Report
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
11/8
02:21 am
valn
Valneva SE (INRLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved ... [Yahoo! Finance]
Medium
Report
Valneva SE (INRLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved ... [Yahoo! Finance]
11/7
01:00 am
valn
Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates
Low
Report
Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates
11/6
07:45 am
valn
Valneva SE (VALN) Q3 2024 Earnings Report Preview: What to Look For [Yahoo! Finance]
High
Report
Valneva SE (VALN) Q3 2024 Earnings Report Preview: What to Look For [Yahoo! Finance]
10/28
03:44 am
valn
High Growth Tech Stocks In France To Explore October 2024 [Yahoo! Finance]
Low
Report
High Growth Tech Stocks In France To Explore October 2024 [Yahoo! Finance]
10/25
03:34 am
valn
High Growth Tech Stocks in France to Watch October 2024 [Yahoo! Finance]
Low
Report
High Growth Tech Stocks in France to Watch October 2024 [Yahoo! Finance]
10/24
03:14 am
valn
Lectra And 2 Other High Growth Tech Stocks In France [Yahoo! Finance]
Low
Report
Lectra And 2 Other High Growth Tech Stocks In France [Yahoo! Finance]
10/22
03:29 am
valn
Exploring 3 High Growth Tech Stocks In France [Yahoo! Finance]
Low
Report
Exploring 3 High Growth Tech Stocks In France [Yahoo! Finance]
10/21
11:45 am
valn
Valneva to Present on Chikungunya at Several Leading Scientific Conferences
Low
Report
Valneva to Present on Chikungunya at Several Leading Scientific Conferences
10/18
03:20 am
valn
High Growth Tech Stocks in France This October 2024 [Yahoo! Finance]
Medium
Report
High Growth Tech Stocks in France This October 2024 [Yahoo! Finance]
10/16
11:45 am
valn
Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4V
Low
Report
Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4V
10/16
03:34 am
valn
High Growth Tech Stocks In France For October 2024 [Yahoo! Finance]
Low
Report
High Growth Tech Stocks In France For October 2024 [Yahoo! Finance]
10/15
03:34 am
valn
High Growth Tech Stocks in France to Watch This October 2024 [Yahoo! Finance]
Low
Report
High Growth Tech Stocks in France to Watch This October 2024 [Yahoo! Finance]
10/14
03:31 am
valn
Believe Leads These 3 High Growth Tech Stocks In France [Yahoo! Finance]
Neutral
Report
Believe Leads These 3 High Growth Tech Stocks In France [Yahoo! Finance]
10/11
08:41 am
valn
Valneva SE (NASDAQ: VALN) had its price target lowered by analysts at HC Wainwright from $23.00 to $20.00. They now have a "buy" rating on the stock.
Low
Report
Valneva SE (NASDAQ: VALN) had its price target lowered by analysts at HC Wainwright from $23.00 to $20.00. They now have a "buy" rating on the stock.